Skip to main content

sec filings

Insider trades

Open-market buys and sales that company insiders report to the SEC on .

Side
Planned sales
Role
RGNX

Updated 10/6/2026, 9:56 AM ET.

RGNX

REGENXBIO Inc.

Buy$949,381

Ciongoli Gregory Austin

Director

102,603 shat $9.25Filed Aug 27, 7:03 PM ETFiling

Read from public SEC filings. Not financial advice.